| Literature DB >> 29104547 |
Jingyu Shi1, Lu Wang1, Yuhong Yao2, Chenyu Zhan1, Na Su3, Xudong Zhao1.
Abstract
Psychosocial intervention trials for youth at clinical high risk (CHR) for psychosis have shown promising effects on treating psychotic symptoms but have not focused on psychosocial functional outcomes, and those studies have been conducted among help-seeking patients; there is a lack of research on non-clinical young CHR individuals. Systemic therapy (ST) is grounded in systemic-constructivist and psychosocial resilience theories. It has a number of advantages that makes it attractive for use with CHR individuals in non-clinical context. The present study evaluated the effect of ST for students at CHR on reducing symptoms and enhancing psychosocial function. This was a single-blind randomized controlled trial for CHR young people comparing ST to supportive therapy with a 6-month treatment. Psychotic and depressive symptoms (DS) as well as self-esteem and social support (SS) were assessed at pre- and posttreatment. 26 CHR individuals were randomly divided into intervention group (n = 13) and control group (n = 13). There were no significant differences in severity of symptoms, level of SS and self-esteem at baseline between the two groups (P > 0.05). At posttreatment, significant improvements in positive and DS as well as SS and self-esteem were observed in the ST group (P < 0.05); in the control group, these improvements were not significant (P > 0.05). The findings indicated that systemic intervention for university students at CHR for psychosis may have a positive effect on symptoms and self-esteem as well as SS in short term. More long-term research is needed to further evaluate this intervention.Entities:
Keywords: clinical high risk; intervention; psychosis; systemic therapy; youth
Year: 2017 PMID: 29104547 PMCID: PMC5655006 DOI: 10.3389/fpsyt.2017.00211
Source DB: PubMed Journal: Front Psychiatry ISSN: 1664-0640 Impact factor: 4.157
Topics and key concepts of systemic therapy.
| Therapeutic phases | Topics | Key issues and techniques | Homework |
|---|---|---|---|
| First phase (2 sessions) | Introduction and join in | Buildup rapport | Write a strength and resource list, including at least 50 points |
| Collection of information | Positive listening, systemic questioning, buildup the first hypotheses, draw genogram | Write down 10 things, which the clients want to do most in the next 3 years | |
| Clarification of therapeutic goals | Inquiry about the expectations, using systemic questioning to clarify the therapeutic goal, which is clear, feasible, and in a positive way of formulation | ||
| Second phase (5 session) | Understanding the context of the identified problem as well as interactive pattern around the identified problem | Shifting the pathology from symptoms to relations. Understanding the meaning and function of the identified problem in an interpersonal system; systemic questioning such as circular questions, exception questions, scaling questions; family boards and timelines | On odd days, the client should act as if the problems become more serious and, on even days, the client should act as if the problems disappear, and meanwhile, he or she observes the reaction of others |
| Reconstruction of the problem and exploring resources and solutions | Finding out and creating diverse possibilities; challenging the certainty of the knowledge of the identified problem; rewriting the self-narrative and reframing, positive connotation | ||
| Making use of the resource and putting the solution into practice | Homework | ||
| Third phase (2 session) | Reinforcement and deepening of changes | Reflecting and reviewing the progress and changes; expand the details of the changes; emphasize the client’s efforts and abilities to make changes; discuss about how to maintain the changes | Observe and write down the sympathetic behaviors |
| Fourth phase (1 session) | Relapse prevention | Considering the risks of relapse and building up a treasure box of strategies | Build up a treasure box of strategies |
Baseline clinical and social demographic characteristics of two groups.
| ST ( | Control ( | |||
|---|---|---|---|---|
| Age mean (SD) | 18.85 (0.987) | 18.85 (1.281) | 0.000 | 1.000 |
| Female (%) | 9 (64.2) | 5 (38.5) | 2.476 | 0.116 |
| Only child (%) | 11 (84.6) | 10 (76.9) | 0.248 | 0.619 |
| Family history (%) | 0 (0.0) | 1 (7.7) | 1.040 | 0.308 |
| PS | 6.85 (3.460) | 7.62 (3.477) | −0.565 | 0.577 |
| NS | 4.54 (4.666) | 3.92 (3.499) | 0.380 | 0.707 |
| DS | 6.62 (5.455) | 7.08 (6.849) | −0.190 | 0.851 |
| Global assessment of functioning scale | 73.62 (5.546) | 72.85 (6.453) | 0.326 | 0.747 |
| Self-esteem | 26.54 (4.824) | 28.08 (4.192) | −0.868 | 0.394 |
| Social support | 56.38 (12.868) | 62.46 (8.491) | −1.421 | 0.168 |
ST, systemic therapy; PS, positive symptoms; NS, negative symptoms; DS, depressive symptoms; SE, self-esteem; SS, social support.
Comparison of changes between groups.
| Measures | Pre-intervention | Post-intervention | Cohen’s | |||
|---|---|---|---|---|---|---|
| Positive symptoms | Systemic therapy (ST) | 6.85 (3.46) | 4.54 (5.08) | 0.53 | 3.426 | 0.005 |
| Control | 7.62 (3.48) | 5.23 (3.90) | 0.65 | 1.934 | 0.077 | |
| NS | ST | 4.54 (4.67) | 3.85 (4.78) | 0.15 | 0.454 | 0.658 |
| Control | 3.92 (3.50) | 3.85 (4.67) | 0.02 | 0.054 | 0.958 | |
| Depressive symptoms | ST | 6.62 (5.46) | 3.00 (4.08) | 0.75 | 3.065 | 0.010 |
| Control | 7.08 (6.85) | 6.46 (8.24) | 0.08 | 0.211 | 0.837 | |
| Global Assessment of Functioning scale | ST | 73.62 (5.55) | 77.00 (9.57) | 0.43 | −1.206 | 0.251 |
| Control | 72.85 (6.45) | 77.15 (10.01) | 0.51 | −1.510 | 0.157 | |
| SE | ST | 26.54 (4.82) | 29.08 (3.73) | 0.59 | −2.980 | 0.011 |
| Control | 28.08 (4.19) | 28.23 (5.09) | 0.03 | −0.148 | 0.885 | |
| SS | ST | 56.31 (12.76) | 62.54 (14. 81) | 0.45 | −2.916 | 0.013 |
| Control | 62.46 (8.49) | 62.08 (12.47) | 0.04 | −0.464 | 0.901 |
Figure 1Improvements in scores of severity of symptoms.
ANOVA of repeated measures.
| Measures | Difference between pre- and post (time) | Time × group | Difference between groups | |||
|---|---|---|---|---|---|---|
| Positive symptoms | 11.157 | 0.003 | 0.003 | 0.957 | 0.266 | 0.611 |
| NS | 0.137 | 0.715 | 0.087 | 0.770 | 0.049 | 0.827 |
| Depressive symptoms | 1.806 | 0.192 | 0.908 | 0.350 | 1.033 | 0.320 |
| Global Assessment of Functioning scale | 3.695 | 0.067 | 0.053 | 0.820 | 0.015 | 0.902 |
| SE | 4.025 | 0.056 | 3.158 | 0.088 | 0.045 | 0.833 |
| SS | 4.797 | 0.038 | 2.154 | 0.155 | 0.665 | 0.423 |
Figure 2Improvements in level of self-esteem and social support.